Financials data is unavailable for this security.
View more
SmartText is unavailable
Gross margin | 34.87% |
---|---|
Net profit margin | 16.81% |
Operating margin | 19.86% |
Return on assets | 13.02% |
---|---|
Return on equity | 17.78% |
Return on investment | 15.16% |
More ▼
Cash flow in USDView more
In 2023, West Pharmaceutical Services did not generate a significant amount of cash. However, the company earned 776.50m from its operations for a Cash Flow Margin of 26.32%. In addition the company used 368.70m on investing activities and also paid 459.60m in financing cash flows.
Cash flow per share | 8.57 |
---|---|
Price/Cash flow per share | 37.01 |
Book value per share | 37.96 |
---|---|
Tangible book value per share | 36.29 |
More ▼
Balance sheet in USDView more
Current ratio | 3.00 |
---|---|
Quick ratio | 2.23 |
Total debt/total equity | 0.0747 |
---|---|
Total debt/total capital | 0.0695 |
More ▼
Growth rates in USD
SmartText is unavailable
Div yield(5 year avg) | 0.23% |
---|---|
Div growth rate (5 year) | 6.20% |
Payout ratio (TTM) | 8.95% |
EPS growth(5 years) | 23.79 |
---|---|
EPS (TTM) vs TTM 1 year ago | -8.55 |
More ▼